JP2023511152A5 - - Google Patents

Info

Publication number
JP2023511152A5
JP2023511152A5 JP2022544247A JP2022544247A JP2023511152A5 JP 2023511152 A5 JP2023511152 A5 JP 2023511152A5 JP 2022544247 A JP2022544247 A JP 2022544247A JP 2022544247 A JP2022544247 A JP 2022544247A JP 2023511152 A5 JP2023511152 A5 JP 2023511152A5
Authority
JP
Japan
Prior art keywords
group
substituted
compound
unsubstituted
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022544247A
Other languages
English (en)
Japanese (ja)
Other versions
JP7726487B2 (ja
JP2023511152A (ja
Filing date
Publication date
Priority claimed from CN202010075139.8A external-priority patent/CN113149977A/zh
Application filed filed Critical
Publication of JP2023511152A publication Critical patent/JP2023511152A/ja
Publication of JP2023511152A5 publication Critical patent/JP2023511152A5/ja
Application granted granted Critical
Publication of JP7726487B2 publication Critical patent/JP7726487B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022544247A 2020-01-22 2021-01-21 呼吸器合胞体ウイルス阻害剤の合成及び使用 Active JP7726487B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010075139.8 2020-01-22
CN202010075139.8A CN113149977A (zh) 2020-01-22 2020-01-22 一类呼吸道合胞病毒抑制剂的合成与用途
PCT/CN2021/073042 WO2021147947A1 (zh) 2020-01-22 2021-01-21 一类呼吸道合胞病毒抑制剂的合成与用途

Publications (3)

Publication Number Publication Date
JP2023511152A JP2023511152A (ja) 2023-03-16
JP2023511152A5 true JP2023511152A5 (cg-RX-API-DMAC7.html) 2024-01-30
JP7726487B2 JP7726487B2 (ja) 2025-08-20

Family

ID=76881779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544247A Active JP7726487B2 (ja) 2020-01-22 2021-01-21 呼吸器合胞体ウイルス阻害剤の合成及び使用

Country Status (6)

Country Link
US (1) US12582661B2 (cg-RX-API-DMAC7.html)
EP (1) EP4095136A4 (cg-RX-API-DMAC7.html)
JP (1) JP7726487B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220130761A (cg-RX-API-DMAC7.html)
CN (2) CN113149977A (cg-RX-API-DMAC7.html)
WO (1) WO2021147947A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113149977A (zh) 2020-01-22 2021-07-23 苏州爱科百发生物医药技术有限公司 一类呼吸道合胞病毒抑制剂的合成与用途
CN116425754A (zh) * 2021-12-30 2023-07-14 苏州爱科百发生物医药技术有限公司 芳杂双环化合物及其抗病毒用途
CN120794971A (zh) * 2024-04-10 2025-10-17 广州医科大学 二氨基嘧啶化合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760230A (en) 1996-10-11 1998-06-02 Bayer Aktiengesellschaft 4, 4'-bridged bis-2, 4-diaminoquinazolines
US8871756B2 (en) 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
ES2665421T3 (es) 2013-06-04 2018-04-25 Acturum Real Estate Ab Compuestos de pirimidina y su uso como moduladores de la gamma secretasa
AR099134A1 (es) * 2014-01-24 2016-06-29 Hoffmann La Roche Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina
WO2017009316A1 (en) 2015-07-16 2017-01-19 F. Hoffmann-La Roche Ag Crystalline forms of n-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1 -dioxido-1,4-benzothiazepin-4(5 h)-yl)-6-methyl-4-quinazolinamine for the treatment of respiratory syncytial virus (rsv) infections
MY197231A (en) 2015-07-22 2023-06-06 Enanta Pharm Inc Benzodiazepine derivatives as rsv inhibitors
CN113149977A (zh) * 2020-01-22 2021-07-23 苏州爱科百发生物医药技术有限公司 一类呼吸道合胞病毒抑制剂的合成与用途

Similar Documents

Publication Publication Date Title
JP6298765B2 (ja) 脳卒中の治療または予防に使用されるするためのフェニルカルバメート化合物
JP2017518959A5 (cg-RX-API-DMAC7.html)
JP2023500532A5 (cg-RX-API-DMAC7.html)
JP2020169171A5 (cg-RX-API-DMAC7.html)
JP2018531982A5 (cg-RX-API-DMAC7.html)
JP2016536316A5 (cg-RX-API-DMAC7.html)
CA2575874A1 (en) Crystalline form of a biphenyl compound
JP2019535723A5 (cg-RX-API-DMAC7.html)
JP2010514758A5 (cg-RX-API-DMAC7.html)
JP2021522262A5 (cg-RX-API-DMAC7.html)
JP2017522304A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP2004307440A (ja) 2−アミノ‐1,3‐プロパンジオール誘導体とその付加塩
JP2022533958A5 (cg-RX-API-DMAC7.html)
JP2018509426A5 (cg-RX-API-DMAC7.html)
JP2007506792A5 (cg-RX-API-DMAC7.html)
JP2010516775A5 (cg-RX-API-DMAC7.html)
JP2007518767A5 (cg-RX-API-DMAC7.html)
JP2017525684A5 (cg-RX-API-DMAC7.html)
JP2007518798A5 (cg-RX-API-DMAC7.html)
JP2021532183A5 (cg-RX-API-DMAC7.html)
HUT70534A (en) 2-amino-4-quinoline-dihydropyridines, process for producing them and their use for producing pharmaceutical compositions
JP2025060830A5 (cg-RX-API-DMAC7.html)
JP2019523265A5 (cg-RX-API-DMAC7.html)
WO2020155952A1 (zh) 一种稠合三环衍生物的制备方法及中间体